晚期黑色素瘤的特征是NLGN4X表达低,导致HIF1A积累
David Schörghofer1, Laurenz Vock1, Madalina A Mirea1
1Institute of Medical Genetics, Center for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, 1090, Austria.
British journal of cancer
|June 20, 2024
概括
神经原蛋白4X (NLGN4X) 损失通过上调HIF1A. 促进黑色素瘤转移,从而促进黑色素瘤转移. 在晚期黑色素瘤中恢复NLGN4X表达减少了瘤生长和改善了患者的存活率,表明其预后价值.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞粘附 细胞粘附
背景情况:
- 转移性黑色素瘤的预后不佳,尽管治疗方面取得了进展.
- 研究了 postsynaptic细胞粘附分子Neuroligin 4X (NLGN4X) 在黑色素瘤进展中的作用.
研究的目的:
- 研究NLGN4X在黑色素瘤进展中的作用.
- 为了确定NLGN4X在人类黑色素瘤的预后价值.
主要方法:
- 对NLGN4X表达和预测值进行组织学样本分析.
- 在人体皮肤有机体中的体外功能损失/获得实验和瘤球分析.
- 全基因组表达分析以阐明分子机制.
主要成果:
- 抑制NLGN4X抑制了希佩尔-林道结合蛋白1 (VBP1) 的下调,导致HIF1A积累和黑色素瘤细胞迁移.
- 在晚期黑色素瘤中恢复NLGN4X减少了人类皮肤器官的瘤生长.
- 高NLGN4X和VBP1水平与更好的患者存活率相关.
结论:
- 减少NLGN4X表明转移性黑色素瘤表型.
- 丢失NLGN4X为黑色素瘤中HIF诱导提供了一个新的机制.
- NLGN4X 作为一种潜在的黑色素瘤预后生物标志物.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Non-LTR Retrotransposons
11.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K


